ES2104223T3 - 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. - Google Patents

2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.

Info

Publication number
ES2104223T3
ES2104223T3 ES94105859T ES94105859T ES2104223T3 ES 2104223 T3 ES2104223 T3 ES 2104223T3 ES 94105859 T ES94105859 T ES 94105859T ES 94105859 T ES94105859 T ES 94105859T ES 2104223 T3 ES2104223 T3 ES 2104223T3
Authority
ES
Spain
Prior art keywords
benzmidazole
isobutyl
amino
methyl
bencilsulfinil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94105859T
Other languages
English (en)
Inventor
Mitsuo Masaki
Tomio Yamakawa
Yutaka Nomura
Hitoshi Matsukura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Application granted granted Critical
Publication of ES2104223T3 publication Critical patent/ES2104223T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

EL 2[[2-(N-ISOBUTIL-N-METIL)AMINO]-BENCILSULFINILO]BENCIMIDAZOL ES EFECTIVO EN EL TRATAMIENTO O PREVENCION DE INFECCIONES DE HELICOBACTER MEDIANTE ADMINISTRACION A PACIENTES QUE SUFREN SU INFECCION.
ES94105859T 1993-04-16 1994-04-15 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. Expired - Lifetime ES2104223T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5113942A JPH06298611A (ja) 1993-04-16 1993-04-16 抗菌剤

Publications (1)

Publication Number Publication Date
ES2104223T3 true ES2104223T3 (es) 1997-10-01

Family

ID=14625066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94105859T Expired - Lifetime ES2104223T3 (es) 1993-04-16 1994-04-15 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.

Country Status (5)

Country Link
US (1) US5576341A (es)
EP (1) EP0621035B1 (es)
JP (1) JPH06298611A (es)
DE (1) DE69404200T2 (es)
ES (1) ES2104223T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150274C1 (ru) * 1996-12-26 2000-06-10 Бачин Игорь Валентинович Стабилизированная водорастворимая композиция трийодида 1,2,3-триалкилбензимидазолия
RU2135476C1 (ru) * 1998-12-07 1999-08-27 Ливицкий Василий Иванович Дийодбромиды 1,2,3-замещенных бензимидазолия и их водорастворимая композиция
SE9904044D0 (sv) * 1999-11-09 1999-11-09 Astra Ab Compounds
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
JP3958748B2 (ja) * 2004-02-20 2007-08-15 株式会社日本生物科学研究所 抗菌剤
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白(rap)-缀合物对肝病症的治疗
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
EP0439453B1 (en) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
ES2066120T3 (es) * 1989-02-10 1995-03-01 Takeda Chemical Industries Ltd Uso de derivados de bencimidazol como agentes antibacterianos.
JPH03161440A (ja) * 1989-11-17 1991-07-11 Yoshitomi Pharmaceut Ind Ltd 抗菌剤

Also Published As

Publication number Publication date
DE69404200D1 (de) 1997-08-21
US5576341A (en) 1996-11-19
EP0621035B1 (en) 1997-07-16
JPH06298611A (ja) 1994-10-25
EP0621035A1 (en) 1994-10-26
DE69404200T2 (de) 1998-01-08

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
CO4970691A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
KR890004709A (ko) 항원충제로서의 아지트로마이신 및 이의 유도체
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
PT880350E (pt) Tratamento de esclerose multipla
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
MX9100042A (es) Reduccion o prevencion de irritacion de la piel por drogas
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
EP0699439A3 (en) Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
SE9601395D0 (sv) New therapeutic treatment 1
EP0744176A3 (en) Methods for inhibiting bone loss
BR0115215A (pt) Método para o tratamento de inflamações
EP1073436A4 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
ES2170377T3 (es) Composicion que contiene quitosana.
CO5031290A1 (es) Formulacion lo
ATE83657T1 (de) Pharmazeutische zusammensetzung.
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
MD196C2 (ro) Izonicotinoilhidrazonă a aldehidei 5-nitro-2-furanice
WO1999065511A3 (en) Composition and method for treatment of pseudomonas infection

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621035

Country of ref document: ES